Resources & Evidence Contact us

Overcoming complications

Together, we can reduce the risk of...

bronchopulmonary dysplasia

retinopathy of prematurity

late-onset sepsis

necrotizing enterocolitis

with clinically proven human milk–based nutritional products

Learn More

Overcoming the complications of prematurity

Recent studies have examined the impact of Prolacta’s products as part of an exclusive human milk diet (EHMD) on reducing common comorbidities associated with prematurity:

The findings of multiple studies indicate that premature infants fed Prolacta’s fortifiers as part of an EHMD have a lower incidence of these complications, compared with infants fed cow milk–based fortifiers.

Overcoming bronchopulmonary dysplasia

Significantly decreased incidence of BPD1,2,3

Overcoming late-onset sepsis

Reduced late-onset sepsis incidence2,4and evaluations1

Overcoming retinopathy of prematurity

Reduced incidence of ROP1,2,3

Overcoming necrotizing enterocolitis

A combined analysis of two randomized clinical studies demonstrates a dose–response relationship that negatively affects patient outcomes. For every 10% increase in the volume of milk containing cow milk–based protein, the risk of NEC increased by 11.8%, surgical NEC by 21%, and sepsis by 17.9%.5

How to bring Prolacta products into your NICU

  1. Identify desired clinical outcomes, such as reducing the incidence of BPD, as well as anticipated economic outcomes
  2. Consult with us to determine the optimal feeding protocol, as well as possibilities for coding, billing, and reimbursement for Prolacta products
  3. Prepare your facility with implementation, staff training, and parent education

Tell us how we can help

Contact one of our nurses

Reach out to a dietitian

Connect with a neonatologist

Coding, billing and reimbursement questions